Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 368

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1C
Chunk 368
---
 regulations;

    ●
    obtaining
    and reviewing a report, at least annually, from the independent registered public accounting firm describing: (i) the
    independent registered public accounting firm’s internal quality-control procedures; (ii) any material issues raised by the
    most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental
    or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and
    any steps taken to deal with such issues; and (iii) all relationships between the independent registered public accounting firm and
    us to assess the independent registered public accounting firm’s independence;

66

    ●
    reviewing
    and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC
    prior to us entering into such transaction; and

    ●
    reviewing
    with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory
    or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published
    reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting
    standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.

Nominating
and Corporate Governance Committee

We
have established a nominating and corporate governance committee. The members of our nominating and corporate governance are John Kim,
Gary Wunderlich and Dr. Zhe Zhang. John Kim serves as chair of the nominating and corporate governance committee. John Kim, Gary Wunderlich
and Dr. Zhe Zhang meet the independent director standard under Nasdaq listing standards applicable to members of the nominating and corporate
governance committee.

The
primary purposes of our nominating and corporate governance committee are to assist the Board of Directors in:

●identifying,
                                            screening and reviewing individuals qualified to serve as directors and recommending to the
                                            Board of Directors candidates for nomination for appointment at the annual general meeting
                                            or to fill vacancies on the Board of Directors;

●developing
                                            and recommending to the Board of Directors and overseeing implementation of our corporate
                                            governance guidelines;

●coordinating
                                            and overseeing the annual self-evaluation of the Board of Directors, its committees, individual
                                            directors and management in the governance of the Company; and

●reviewing
                                            on a regular basis our overall